Pathways of Eicosanoid Metabolism
Condition:   Metabolism of Prostaglandin D2 Interventions:   Dietary Supplement: niacin;   Drug: aspirin;   Other: PGD2 Sponsors:   Vanderbilt University;   Vanderbilt University Medical Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2020 Category: Research Source Type: clinical trials

Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
Conditions:   Mild Cognitive Impairment;   Alzheimer Disease Intervention:   Drug: Nicotinamide riboside Sponsors:   Mclean Hospital;   National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2020 Category: Research Source Type: clinical trials

Visual Surround Suppression and Perceptual Expectation Under Psilocybin
Condition:   Perception Disturbance Interventions:   Drug: Psilocybin;   Drug: Niacin Sponsor:   University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2020 Category: Research Source Type: clinical trials

Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly
Condition:   COVID Interventions:   Dietary Supplement: Nicotinamide riboside;   Dietary Supplement: Placebo Sponsors:   University of Copenhagen;   Bispebjerg Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials

Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly
Condition:   COVID Interventions:   Dietary Supplement: Nicotinamide riboside;   Dietary Supplement: Placebo Sponsors:   University of Copenhagen;   Bispebjerg Hospital;   Elysium Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials

Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly
Condition:   COVID Interventions:   Dietary Supplement: Nicotinamide riboside;   Dietary Supplement: Placebo Sponsors:   University of Copenhagen;   Bispebjerg Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials

A Two-Year Observational Follow-up Study of Subjects With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control
Condition:   Major Depressive Disorder Intervention:   Other: No intervention will be administered as part of this study. Sponsor:   Usona Institute Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2020 Category: Research Source Type: clinical trials